These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma. Bhattacharjee R; Devi A; Mishra S J Mol Model; 2015 Oct; 21(10):272. PubMed ID: 26419972 [TBL] [Abstract][Full Text] [Related]
63. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols. Cenedella RJ Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866 [TBL] [Abstract][Full Text] [Related]
64. Polyphenols from Citrus Tacle Grande F; Occhiuzzi MA; Perri MR; Ioele G; Rizzuti B; Statti G; Garofalo A Molecules; 2021 Sep; 26(18):. PubMed ID: 34577189 [TBL] [Abstract][Full Text] [Related]
65. Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure. Pak VV; Kim SH; Koo M; Lee N; Shakhidoyatov KM; Kwon DY Biopolymers; 2006; 84(6):586-94. PubMed ID: 16886212 [TBL] [Abstract][Full Text] [Related]
67. Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors. Argüelles N; Sánchez-Sandoval E; Mendieta A; Villa-Tanaca L; Garduño-Siciliano L; Jiménez F; Cruz Mdel C; Medina-Franco JL; Chamorro-Cevallos G; Tamariz J Bioorg Med Chem; 2010 Jun; 18(12):4238-48. PubMed ID: 20576575 [TBL] [Abstract][Full Text] [Related]
68. Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from Aulifa DL; Amirah SR; Rahayu D; Megantara S; Muchtaridi M Molecules; 2024 Jun; 29(13):. PubMed ID: 38998937 [TBL] [Abstract][Full Text] [Related]
69. Potential Effect of Baobab's Polyphenols as Antihyperlipidemic Agents: In Silico Study. Alameen AA; Alothman MR; Al Wahibi MS; Abdullah EM; Ali R; Abdalla M; Fattiny SZA; Elsayim R Molecules; 2023 Aug; 28(16):. PubMed ID: 37630364 [No Abstract] [Full Text] [Related]
70. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit. Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415 [TBL] [Abstract][Full Text] [Related]
71. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer. Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759 [TBL] [Abstract][Full Text] [Related]
72. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor. Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050 [TBL] [Abstract][Full Text] [Related]
73. Kinetic properties and inhibition of Trypanosoma cruzi 3-hydroxy-3-methylglutaryl CoA reductase. Hurtado-Guerrrero R; Peña-Díaz J; Montalvetti A; Ruiz-Pérez LM; González-Pacanowska D FEBS Lett; 2002 Jan; 510(3):141-4. PubMed ID: 11801242 [TBL] [Abstract][Full Text] [Related]
74. Computational study of conformational changes in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding. Costa CHS; Oliveira ARS; Dos Santos AM; da Costa KS; Lima AHLE; Alves CN; Lameira J J Biomol Struct Dyn; 2019 Oct; 37(16):4374-4383. PubMed ID: 30470158 [TBL] [Abstract][Full Text] [Related]
75. Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. Tabernero L; Bochar DA; Rodwell VW; Stauffacher CV Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7167-71. PubMed ID: 10377386 [TBL] [Abstract][Full Text] [Related]
76. Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase. Tuansulong KA; Hutadilok-Towatana N; Mahabusarakam W; Pinkaew D; Fujise K Phytother Res; 2011 Mar; 25(3):424-8. PubMed ID: 20734327 [TBL] [Abstract][Full Text] [Related]
77. Partial cloning, tissue distribution and effects of epigallocatechin gallate on hepatic 3-hydroxy-3-methylglutaryl-CoA reductase mRNA transcripts in goldfish (Carassius auratus). Cocci P; Mosconi G; Palermo FA Gene; 2014 Jul; 545(2):220-5. PubMed ID: 24835314 [TBL] [Abstract][Full Text] [Related]
78. Cloning and characterization of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) gene from Paris fargesii Franch. Liang Y; Jiang X; Hu Q; Li X; Yin H; Li D; Zhang Y; Liu X Indian J Biochem Biophys; 2014 Jun; 51(3):201-6. PubMed ID: 25204081 [TBL] [Abstract][Full Text] [Related]
79. (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. Ahmad S; Madsen CS; Stein PD; Janovitz E; Huang C; Ngu K; Bisaha S; Kennedy LJ; Chen BC; Zhao R; Sitkoff D; Monshizadegan H; Yin X; Ryan CS; Zhang R; Giancarli M; Bird E; Chang M; Chen X; Setters R; Search D; Zhuang S; Nguyen-Tran V; Cuff CA; Harrity T; Darienzo CJ; Li T; Reeves RA; Blanar MA; Barrish JC; Zahler R; Robl JA J Med Chem; 2008 May; 51(9):2722-33. PubMed ID: 18412317 [TBL] [Abstract][Full Text] [Related]
80. Isoflavones inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase in vitro. Sung JH; Lee SJ; Park KH; Moon TW Biosci Biotechnol Biochem; 2004 Feb; 68(2):428-32. PubMed ID: 14981309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]